Article Details
Retrieved on: 2025-09-21 03:16:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wuhan YZY Biopharma ( HKG:2496 ) First Half 2025 Results Key Financial Results Revenue: CN¥44.4m (up by CN¥41.5m from...
Article found on: simplywall.st
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here